BGB-16673-101

Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Beigene Study ID info

BGB-16673-101

ClinicalTrials.gov ID info

EudraCT Number info

2022-502157-33-00

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents